精神病性障碍患者及其未患病同胞成年期认知功能研究
该研究基于EU-GEI和GROUP两项研究的横断面数据,纳入8455名18至65岁参与者,比较精神病性障碍患者、其未患病同胞与对照者的认知功能。患者在所有认知功能上表现中至大程度缺陷,同胞在智商、言语知识和工作记忆上表现小程度缺陷;缺陷幅度与年龄无关,但首发性患者比前驱期患者表现更差。调整大麻使用、症状严重度和整体功能后,同胞缺陷减弱,患者缺陷仍显著但减半;抗精神病药物也解释约一半患者缺陷。
要点
- 患者在所有认知功能上表现中至大程度缺陷,同胞在智商、言语知识和工作记忆上表现小程度缺陷。
- 认知缺陷幅度与年龄无关,但首发性患者比前驱期患者表现更差。
- 调整大麻使用、症状严重度和整体功能后,患者缺陷仍显著但减半;抗精神病药物解释约一半缺陷。
核心结论
- 精神病性障碍患者存在广泛中至大程度认知缺陷,未患病同胞存在小程度缺陷,且缺陷幅度不随年龄变化。
- 言语知识和工作记忆缺陷可能特异地反映精神病性障碍的家族易感性。
- 大麻使用、症状严重度、整体功能和抗精神病药物等可干预因素解释患者认知缺陷的显著部分。
研究设计与样本
- 基于EU-GEI和GROUP研究的横断面数据,共纳入8455名18至65岁参与者,包括患者2883名、未患病同胞2271名和对照者3301名。
- 使用简版WAIS-III测量言语知识、工作记忆、视空间加工、加工速度和智商。
主要发现
- 患者在所有认知功能上表现中至大程度缺陷(ES范围=-0.45至-0.73,p<0.001)。
- 同胞在智商、言语知识和工作记忆上表现小程度缺陷(ES=-0.14至-0.33,p<0.001)。
- 认知缺陷幅度与参与者年龄无关,老年和年轻患者的缺陷程度无显著差异。
- 首发性患者比前驱期患者表现更差(ES范围=-0.88至-0.60,p<0.001)。
- 调整大麻使用、症状严重度和整体功能后,同胞缺陷减弱,患者缺陷仍显著但减半(ES范围=-0.13至-0.38,p<0.01);抗精神病药物解释约一半患者缺陷(ES范围=-0.21至-0.43,p<0.01)。
临床怎么用
- 临床评估精神病性障碍患者时应关注言语知识和工作记忆等认知功能,并考虑其家族易感性。
- 管理患者认知缺陷时需综合评估大麻使用、症状严重度、整体功能和抗精神病药物等可干预因素。
局限性
- 研究为横断面设计,无法推断认知功能随年龄变化的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Important questions remain about the profile of cognitive impairment in psychotic disorders across adulthood and illness stages. The age-associated profile of familial impairments also remains unclear, as well as the effect of factors, such as symptoms, functioning, and medication. Using cross-sectional data from the EU-GEI and GROUP studies, comprising 8455 participants aged 18 to 65, we examined cognitive functioning across adulthood in patients with psychotic disorders (n = 2883), and their unaffected siblings (n = 2271), compared to controls (n = 3301). An abbreviated WAIS-III measured verbal knowledge, working memory, visuospatial processing, processing speed, and IQ. Patients showed medium to large deficits across all functions (ES range = -0.45 to -0.73, p < 0.001), while siblings showed small deficits on IQ, verbal knowledge, and working memory (ES = -0.14 to -0.33, p < 0.001). Magnitude of impairment was not associated with participant age, such that the size of impairment in older and younger patients did not significantly differ. However, first-episode patients performed worse than prodromal patients (ES range = -0.88 to -0.60, p < 0.001). Adjusting for cannabis use, symptom severity, and global functioning attenuated impairments in siblings, while deficits in patients remained statistically significant, albeit reduced by half (ES range = -0.13 to -0.38, p < 0.01). Antipsychotic medication also accounted for around half of the impairment in patients (ES range = -0.21 to -0.43, p < 0.01). Deficits in verbal knowledge, and working memory may specifically index familial, i.e., shared genetic and/or shared environmental, liability for psychotic disorders. Nevertheless, potentially modifiable illness-related factors account for a significant portion of the cognitive impairment in psychotic disorders.
引用
- Velthorst E, Mollon J, Murray RM, et al. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings. Mol Psychiatry. 2021. PMID: 33414498. doi:10.1038/s41380-020-00969-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。